Literature DB >> 19470881

Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.

Laura C Plantinga1, Edgar R Miller, Lesley A Stevens, Rajiv Saran, Kassandra Messer, Nicole Flowers, Linda Geiss, Neil R Powe.   

Abstract

Recent guidelines recommending more aggressive blood pressure control in patients with chronic kidney disease have unknown impact. We assessed trends in and predictors of blood pressure control in 8829 adult National Health and Nutrition Examination Survey 1999-2006 participants with hypertension (self-report, measured blood pressure, or use of antihypertensive medications), without (n=7178) and with (n=1651) chronic kidney disease. Uncontrolled blood pressure was defined as follows: general definition, systolic blood pressure > or =140 mm Hg and diastolic blood pressure > or =90 mm Hg, and disease-specific definition, systolic blood pressure > or =130 mm Hg and diastolic blood pressure > or =85 mm Hg (1999-2002) and systolic blood pressure > or =130 mm Hg and diastolic blood pressure > or =80 mm Hg (2003-2006) for those with chronic kidney disease (estimated glomerular filtration rate: <60 mL/min per 1.73 m(2)) or diabetes mellitus (self-report). Proportions with uncontrolled blood pressure in 1999-2006 were greater in those with chronic kidney disease versus those without chronic kidney disease (51.5% versus 48.7% [general definition: P=0.122] and 68.8% versus 51.7% [disease-specific definition: P<0.001]). In those with chronic kidney disease, there were significant decreases in uncontrolled blood pressure over time (55.9% to 47.8% [general definition: P=0.011]). With adjustment for demographic, socioeconomic, and clinical variables, older age (P<0.001) and lack of antihypertensive treatment (P<0.001) were associated with uncontrolled blood pressure, regardless of chronic kidney disease status; nonwhite race (P=0.002) was associated in those without chronic kidney disease, whereas female sex (P=0.030) was associated in those with chronic kidney disease. Multiple medications (P<0.001) and angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (P=0.001) were associated with less uncontrolled blood pressure. Although some improvement has occurred over time, uncontrolled blood pressure remains highly prevalent, especially in subjects with chronic kidney disease and in nonwhites, older persons, and women. Therapy appears suboptimal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470881      PMCID: PMC2720323          DOI: 10.1161/HYPERTENSIONAHA.109.129841

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  30 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study.

Authors:  Bruce M Psaty; Teri A Manolio; Nicholas L Smith; Susan R Heckbert; John S Gottdiener; Gregory L Burke; Joel Weissfeld; Paul Enright; Thomas Lumley; Neil Powe; Curt D Furberg
Journal:  Arch Intern Med       Date:  2002-11-11

3.  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures.

Authors: 
Journal:  Vital Health Stat 1       Date:  1994-07

4.  Impact of high-normal blood pressure on the risk of cardiovascular disease.

Authors:  R S Vasan; M G Larson; E P Leip; J C Evans; C J O'Donnell; W B Kannel; D Levy
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

Authors:  Rajiv Agarwal; Allen R Nissenson; Daniel Batlle; Daniel W Coyne; J Richard Trout; David G Warnock
Journal:  Am J Med       Date:  2003-09       Impact factor: 4.965

Review 7.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

8.  Factors related to poor control of blood pressure with antihypertensive drug therapy.

Authors:  Erkki Jokisalo; Hannes Enlund; Pirjo Halonen; Jorma Takala; Esko Kumpusalo
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

9.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

Authors:  V L Burt; J A Cutler; M Higgins; M J Horan; D Labarthe; P Whelton; C Brown; E J Roccella
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  46 in total

1.  Approach to cardiovascular disease prevention in patients with chronic kidney disease.

Authors:  Cristina Karohl; Paolo Raggi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 2.  Chronic kidney disease and albuminuria in arterial hypertension.

Authors:  Giovanna Leoncini; Francesca Viazzi; Roberto Pontremoli
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

Review 3.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

4.  Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study.

Authors:  Csaba P Kovesdy; Anthony J Bleyer; Miklos Z Molnar; Jennie Z Ma; John J Sim; William C Cushman; L Darryl Quarles; Kamyar Kalantar-Zadeh
Journal:  Ann Intern Med       Date:  2013-08-20       Impact factor: 25.391

5.  Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Authors:  Paul Muntner; Suzanne E Judd; Marie Krousel-Wood; William M McClellan; Monika M Safford
Journal:  Am J Kidney Dis       Date:  2010-05-14       Impact factor: 8.860

Review 6.  Blood pressure level and kidney disease progression: do we really need to go to 130/80 mm Hg?

Authors:  Bassam G Abu Jawdeh; Mahboob Rahman
Journal:  Curr Hypertens Rep       Date:  2009-10       Impact factor: 5.369

Review 7.  The role of the kidney in regulating arterial blood pressure.

Authors:  Hani M Wadei; Stephen C Textor
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

8.  Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study.

Authors:  Benedicte Stengel; Marie Metzger; Marc Froissart; Muriel Rainfray; Claudine Berr; Christophe Tzourio; Catherine Helmer
Journal:  Nephrol Dial Transplant       Date:  2011-06-15       Impact factor: 5.992

9.  Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial.

Authors:  Rajiv Agarwal; Andrew E Cramer; Mary Balmes-Fenwick; Arjun D Sinha; Fangqian Ouyang; Wanzhu Tu
Journal:  Am J Nephrol       Date:  2020-07-14       Impact factor: 3.754

Review 10.  Burden, access, and disparities in kidney disease.

Authors:  Deidra C Crews; Aminu K Bello; Gamal Saadi
Journal:  J Nephrol       Date:  2019-02       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.